Clinical Trial Update: Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating albumin-bound paclitaxel in combination with bevacizumab for platinum-resistant recurrent ovarian cancer (status not disclos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Carcinoma
• Platinum-resistant Ovarian Cancer

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Lei Li | Conditions: Ovarian Carcinoma, Platinum-resistant Ovarian Cancer | Phase 2 | Status: UNKNOWN